
Optimum Expands its Team with Senior Investor Relations and Communications Hires Jonathan Edwards and Hana Malik
14 February 2023 – Optimum Strategic Communications (“Optimum”),…

Novo Holdings Venture Investments team Newsletter
The Novo Holdings Venture Investments team has published its…

Sequana Medical announces 2022 Full Year Results and 2023 Outlook
alfapump® – successful primary endpoint read-out of North…

Women in Life Science Denmark announce The First Women in Leadership Network to Support Diversity, Equality and Inclusion across the Life Sciences Industry launched in Denmark
New Professional Network for Female Executives and Specialists…

Structural proteins for the development of sustainable materials: BRAIN Biotech and AMSilk cooperate to develop high-performance bio-based protein fibers
Zwingenberg/Neuried, February 8, 2023 – Creating a better…

Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure
Data from GLP[i] animal studies demonstrate safety of second-generation…

Chong Kun Dang Pharm Licenses Synaffix ADC Technology, Adds Novel ADC Candidate to Oncology Pipeline
Synaffix to provide access to proprietary Antibody-Drug…

Sequana Medical announces grant of additional DSR® patent in United States
Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext…

Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical Officer
Dr. Gericke brings extensive experience in the research and…

ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization
Newly appointed CFO with significant experience in medical…

Neuraxpharm announces closing of acquisition of established products from Sanofi
Düsseldorf and Barcelona – February 1, 2023 – Neuraxpharm…

Pre-launch of MED3000 Eroxon™ ahead of H1 2023 launch
Futura Medical plc (AIM: FUM), a pharmaceutical company developing…

Destiny Pharma plc – US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections
Brighton, United Kingdom – 25 January 2023 – Destiny Pharma…

STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference
Data demonstrates that STC-15, an oral METTL3 inhibitor,…

2022 Novo Holdings Seed Investments team Re-view/Business Update
Two successful exits – Syndesi and BioPhero
Four portfolio…

Neuraxpharm completes its presence in the Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg
Belgium team to expand under Country Manager, Dr Pierre-Hervé…

NeoPhore completes extension to Series B financing to further advance discovery pipeline
Scientific milestones achieved significantly ahead of schedule
Cambridge,…

Poolbeg announces strategic expansion of POLB 001 into oncology
Complements strong initial data from LPS challenge trial and…

STORM Therapeutics Expands R&D Leadership Team
Matthew Fyfe joins as Senior Vice President of Therapeutics
…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
Optimum Strategic Communications’ specialist team has an in-depth understanding of how to communicate complex science to investors and corporate stakeholders. Optimum helps life science companies on their journey as they grow and has been trusted by hundreds of healthcare clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York